From Financial Modeling Prep: 2025-03-28 10:00:00

In summary, VolitionRx Limited, trading as NYSEAMERICAN:VNRX, is gearing up to announce its quarterly earnings on March 31, 2025, with expected earnings per share of -$0.06 and revenue of $545,340. Despite a negative P/E ratio, the company’s high price-to-sales ratio reflects optimistic investor outlook. However, a low current ratio suggests potential liquidity challenges.



Read more at Financial Modeling Prep:: VolitionRx Limited’s Upcoming Earnings Report: A D…